Clinigen Group plc Holding(s) in Company (1679C)
February 18 2022 - 6:12AM
UK Regulatory
TIDMCLIN
RNS Number : 1679C
Clinigen Group plc
18 February 2022
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the Clinigen Group PLC
underlying issuer of existing shares
to which voting rights are attached
(ii) :
-----------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify)(iii) (-) Acquisition of voting rights as
a result of introduction of new holding company following a scheme
of arrangement
----
3. Details of person subject to the notification obligation (iv)
Name Elliott Investment Management, L.P
City and country of registered office Delaware
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name Elliott International, L.P.
Elliott Associates, L.P.
-----------------------------------------------
City and country of registered office Grand Cayman, Cayman Islands; Delaware,
(if applicable) US;
-----------------------------------------------
5. Date on which the threshold was 16/02/2022
crossed or reached (vi) :
-----------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 18/02/2022
-----------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ ---------------------- ---------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 8.661% 0 % 8.661% 133,366,726
------------------ ---------------------- ---------------- --------------------
Position of
previous notification
(if
applicable) 14.767% 0 % 14.767%
------------------ ---------------------- ---------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
----------------------------
GB00B89J2419 11,551,258 8.661%
---------------------- ---------------------------- ------------------------- ---------------------
SUBTOTAL 8. A 11,551,258 8.661%
---------------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting
financial date (x) Conversion Period rights that may rights
instrument (xi) be acquired if
the instrument
is
exercised/converted.
------------ ------------------------------- -------------------------------- ---------------------
SUBTOTAL 8. B 1
------------------------------- -------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date (x) Conversion cash voting rights rights
instrument Period (xi) settlement
(xii)
----------------- -------------------- --------------------- --------------------
SUBTOTAL 8.B.2
--------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights X
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (xiv) (please add additional
rows as necessary)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
Paul Singer -Elliott
International, L.P 5.976% 0% 5.976%
---------------------- --------------------- ------------------------
Paul Singer -Elliott
Associates, L.P 2.685% 0% 2.685%
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-----------------------------------------------
The number and % of voting rights
held
-----------------------------------------------
The date until which the voting rights
will be held
-----------------------------------------------
11. Additional information (xvi)
Place of completion London, UK
Date of completion 18/02/2022
-----------
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
HOLEAAAPFFEAEFA
(END) Dow Jones Newswires
February 18, 2022 07:12 ET (12:12 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Clinigen Group Plc (London Stock Exchange): 0 recent articles
More Clinigen Group Plc News Articles